CFCThe Compounder Score
HIMS logo

HIMS — Hims & Hers Health, Inc.

Drug Manufacturers - Specialty & GenericHealthcare

$19.73

+$0.00 (+0.00%)

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.

Market Cap

$4.62B

Forward P/E

48.8x

52-Week Range

$14.52$40.02

HIMS Price History

Current price

$19.73

HIMS return (1Y)

-45.3%

S&P 500 return (1Y)

+12.2%

vs S&P 500

-57.5 pts

Revenue vs. Net Income

$2.3B

Revenue · FY2025

Annual. Net margin is shown under each year.

RevenueNet income (green profit, red loss)

Free Cash Flow

$57.4M

FCF · FY2025

Annual. FCF margin is shown under each year.

Return on Capital Employed (ROCE)

6.0%

ROCE · FY2025

Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.

Total Assets vs. Total Liabilities

1.3x

Assets ÷ liabilities · FY2025

Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.

Total assetsTotal liabilities

CapEx as % of Revenue

10.3%

CapEx · FY2025

Annual. Green at or under the 5% maximum target, red above it.

Shares Outstanding

+9.0%

Dilution · FY2025

Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).